HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart Failure
Clinical trial NCT04450576 · UNKNOWN
Trial details
- NCT number
- NCT04450576
- Sponsor
- Parkview Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-20
- Primary completion
- 2020-10-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.